Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 111 Magnetic Resonance Spectroscopy 111 Cyclophosphamide 109 pembrolizumab 78 Radiotherapy 77 Nivolumab 74 Cisplatin 69 fludarabine 68 Carboplatin 61 Biopsy 53 Paclitaxel 46 Standard of Care 45 Radiosurgery 41 Gemcitabine 41 Dexamethasone 40 Doxorubicin 38 Rituximab 37 venetoclax 36 Radiation 36 Blood Specimen Collection 36 fludarabine phosphate 35 Cytarabine 35 Surveys and Questionnaires 34 Bevacizumab 32 Capecitabine 31 Radiotherapy, Intensity-Modulated 30 Ipilimumab 28 Etoposide 28 durvalumab 27 Temozolomide 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × penpulimab × 30 days × Clear all

NCT07612098 2026-05-28

SPARE-04

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡